IL1B and non-small cell lung carcinoma: Interestingly, inhibition of COX-2 using aspirin (1 mM) and celecoxib (25 μM), IL-1β-mediated suppression of miR-101, and IL-1β-mediated activation of Lin28B inhibited NSCLC cell proliferation and migration.